These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6386739)

  • 1. [Plasma exchange therapy in a patient with familial hypercholesteremia and generalized arteriosclerosis].
    Schrecker O; Thies K; Schlierf G
    Internist (Berl); 1984 Sep; 25(9):574-6. PubMed ID: 6386739
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
    Branchi A; Sommariva D; Tirrito M; Bonfiglioli D; Pini C; Scandiani L; Orlandi S; Fasoli A
    Clin Ter; 1987 Jul; 122(1):17-23. PubMed ID: 2973892
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.
    Dairou F; Rottembourg J; Truffert J; Assogba U; Bruckert E; de Gennes JL; Jacobs C
    Beitr Infusionsther; 1988; 23():152-9. PubMed ID: 2484771
    [No Abstract]   [Full Text] [Related]  

  • 4. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
    Lowry RP; Soltys G; Mangel R; Kwiterovitch P; Sniderman AD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2229-32. PubMed ID: 3547921
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of apoproteins A and B, lipoproteins and plasma lipids during treatment with bezafibrate in various forms of hyperlipoproteinemia].
    Saitta A; Bonaiuto M; Lanzafame F; Mileto A; Pernice F; Cinquegrani M; Mazza G; Micali G; Pangallo A; Fodale P
    Clin Ter; 1988 Mar; 124(5):373-81. PubMed ID: 2974348
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum thromboxane B2 and prostaglandin F2 alpha in familial combined hyperlipoproteinemia and familial hypercholesterolemia].
    Sziegoleit W; Wichmann T; Block HU; Taube C; Mest HJ
    Wien Klin Wochenschr; 1991; 103(8):227-31. PubMed ID: 1858388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresis.
    Riesen WF; Sturzenegger E; Imhof C; Descoeudres C; Mordasini R; Oetliker OH
    Prog Clin Biol Res; 1988; 255():337-46. PubMed ID: 3422496
    [No Abstract]   [Full Text] [Related]  

  • 8. New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
    Yamamoto K; Fukushima N; Ozaki I; Setoguchi Y; Yanagita T; Sakai T
    Artery; 1991; 18(3):133-49. PubMed ID: 2069518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive lipid lowering treatment in coronary atherosclerosis.
    Stalenhoef AF; Kroon AA; Aengevaeren WR
    Cardiologia; 1997 Sep; 42(9):935-40. PubMed ID: 9369038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of apolipoproteins is better than routinely measured traditional lipids].
    Kallner A; Estonius M
    Lakartidningen; 2006 Mar 8-14; 103(10):753-6, 758. PubMed ID: 16610202
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical, clinical, epidemiologic, genetic, and pathologic data in the pediatric age group relevant to the cholesterol hypothesis.
    Kwiterovich PO
    Pediatrics; 1986 Aug; 78(2):349-62. PubMed ID: 3090513
    [No Abstract]   [Full Text] [Related]  

  • 12. Triglyceride and Lp(a) concentrations in hyperapobetalipoproteinemia.
    Sorell L; Simón R
    Clin Chim Acta; 2000 Apr; 294(1-2):199-203. PubMed ID: 10809583
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with plasma-exchange in homozygous familial hypercholesterolaemia.
    Postiglione A; Thompson GR
    Prog Clin Biol Res; 1985; 188():213-20. PubMed ID: 3903770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma exchange and related forms of therapy in severe familial hypercholesterolemia].
    Keller C
    Verh Dtsch Ges Inn Med; 1986; 92():419-24. PubMed ID: 3811543
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nutrition and plasma apoproteins B and A-I].
    Khaltaev NG; Perova NV; Dobordzhginidze LM; Metel'skaia VA; Grishenkov EA
    Ter Arkh; 1987; 59(5):108-12. PubMed ID: 3112987
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening and follow-up of infants with dyslipoproteinemia.
    Roseneu M; Van Biervliet JP
    Prog Clin Biol Res; 1985; 188():79-86. PubMed ID: 3933016
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma exchange in type II hypercholesterolemia.
    Kamanabroo D; Ulrich K; Gröbe H; Assmann G
    Prog Clin Biol Res; 1988; 255():347-56. PubMed ID: 3340644
    [No Abstract]   [Full Text] [Related]  

  • 19. The child is father of the man.
    Glueck CJ
    Pediatrics; 1986 Aug; 78(2):364-8. PubMed ID: 3526271
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radical therapy of refractory hyperlipidemia: extracorporeal cholesterol elimination].
    Kostner KM
    Wien Med Wochenschr; 1994; 144(12-13):333-5. PubMed ID: 8650940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.